An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease. (2017)
Attributed to:
Confidence in Concept 2012 - Cambridge
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00415-017-8647-0
PubMed Identifier: 29075837
Publication URI: http://europepmc.org/abstract/MED/29075837
Type: Journal Article/Review
Volume: 264
Parent Publication: Journal of neurology
Issue: 12
ISSN: 0340-5354